Oral simvastatin treatment in relapsing-remitting multiple sclerosis
Top Cited Papers
- 1 May 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 363 (9421), 1607-1608
- https://doi.org/10.1016/s0140-6736(04)16205-3
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Statins as immunomodulatorsNeurology, 2002
- Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]Neurology, 2002
- Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitisJournal of Neuroscience Research, 2001
- Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages.JCI Insight, 1997